"CRG to jeden z wiodących ośrodków badań klinicznych w Polsce, realizujący najwyższej jakości badania kliniczne faz II i III. Jesteśmy ogniwem łączącym pacjenta z najnowszymi osiągnięciami medycyny, a dzięki współpracy z czołowymi przedstawicielami branży farmaceutycznej razem dążymy do poprawy jakości życia ludzi na całym świecie."

During the past decade, Clinical Research Group Sp. z o.o. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Group Sp. z o.o." #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Adial Pharmaceuticals" with 1 trials sponsored, "Akros Pharma Inc." with 1 trials sponsored and "AnaptysBio, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Group Sp. z o.o." #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Group Sp. z o.o." are "Atopic Dermatitis" (6 trials), "Psoriasis" (3 trials), "Skin Diseases" (2 trials), "Alcohol Use Disorder" (1 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "Clinical Research Group Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Clinical Research Group Sp. z o.o." are "Drug" (7 trials), "Biological" (4 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Lebrikizumab" (3 trials), "BMS-986165" (2 trials), "AD04 (ondansetron)" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Group Sp. z o.o." are 10 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Group Sp. z o.o.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Clinical Research Group Sp. z o.o., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Group Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".